NEW YORK (GenomeWeb News) – Bruker has sold $240 million worth of senior notes through a private placement, it said in a filing with the US Securities and Exchange Commission Thursday.
The firm sold four series of notes in the placement: $20 million of 3.16 percent Series 2012A Senior Notes, Tranche A, due Jan. 18, 2017; $15 million of 3.74 percent Series 2012A Senior Notes, Tranche B, due Jan. 18, 2019; $105 million of 4.31 percent Series 2012A Senior Notes, Tranche C, due Jan. 18, 2022; and $100 million of 4.46 percent Series 2012A Senior Notes, Tranche D, due Jan. 18, 2024.
Bruker noted that under the terms of the note purchase agreement it may sell additional senior notes up to an aggregate amount of $600 million.
It intends to use the proceeds to reduce outstanding debt under its revolving credit facilities and for general corporate purposes.